MedPath

Effect evaluation of herbal supplementation from the combination of sugarcane, black myrobalan and mastic along with the treatment protocol of the Ministry of Health on the course of coronavirus disease

Phase 2
Conditions
ew Corona virus disease 2019.
new Corona virus disease 2019
U07.1
Registration Number
IRCT20200415047082N1
Lead Sponsor
Jahrom University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

All patients admitted with a diagnosis of COVID-19
COVID-19 patients who are willing to participate in study
The patient should not be among high-risk groups, such as breastfeeding or pregnant or etc.
Age> 18 years old
The patient does not have a specific underlying disease Study

Exclusion Criteria

People who are under 18 years of age
People who are among the high-risk group
People who have a specific underlying disease
People who are characterized as severe in the illness course

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Symptoms of disease. Timepoint: During the hospital stay, on a daily basis. Method of measurement: The severity of patient's clinical symptoms is measured on the basis of visual analog scale.;Vital Signs. Timepoint: During the hospital stay, on a daily basis. Method of measurement: Vital signs monitoring device.;C-Reactive Protein. Timepoint: During the hospital stay, on a daily basis. Method of measurement: C-Reactive Protein test.
Secondary Outcome Measures
NameTimeMethod
Pulmonary damages after illness. Timepoint: At the beginning of the study and 14 and 30 days after taking herbal supplements. Method of measurement: Chest Computed Tomography Scan.
© Copyright 2025. All Rights Reserved by MedPath